Zoetis (ZTS) Non-Current Deferred Tax Liability (2012 - 2026)

Zoetis (ZTS) reported Non-Current Deferred Tax Liability of $130.0 million for Q1 2026, down 19.25% year-over-year from $161.0 million in Q1 2025, and down 5.11% quarter-over-quarter from $137.0 million in Q4 2025.

Zoetis (ZTS) Non-Current Deferred Tax Liability (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Non-Current Deferred Tax Liability data on file, last reported at $130.0 million in Q1 2026.

  • Non-Current Deferred Tax Liability for Q1 2026 came in at $130.0 million, down 19.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $130.0 million (down 19.25% YoY), and the FY2025 annual result was $137.0 million, down 17.96% from the prior year.
  • Non-Current Deferred Tax Liability declined to $130.0 million in Q1 2026 per ZTS's latest filing, from $137.0 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $287.0 million in Q1 2022 and troughed at $121.0 million in Q2 2023.
  • A 5-year average of $170.5 million and a median of $156.0 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
  • The sharpest annual moves came in 2023 and 2024: Non-Current Deferred Tax Liability slumped 55.84% in 2023, then soared 44.63% in 2024.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $142.0 million in 2022, then rose by 2.82% to $146.0 million in 2023, then rose by 14.38% to $167.0 million in 2024, then slipped by 17.96% to $137.0 million in 2025, then dropped by 5.11% to $130.0 million in 2026.
  • Business Quant data shows ZTS's Non-Current Deferred Tax Liability at $130.0 million in Q1 2026, $137.0 million in Q4 2025, and $147.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Liquidia 5.64 Bn 5.42 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 130.00 Mn
Mar 31, 2026 130.00 Mn
Dec 31, 2025 137.00 Mn
Dec 31, 2025 137.00 Mn
Sep 30, 2025 147.00 Mn
Sep 30, 2025 147.00 Mn
Jun 30, 2025 156.00 Mn
Jun 30, 2025 156.00 Mn
Mar 31, 2025 161.00 Mn
Mar 31, 2025 161.00 Mn
Dec 31, 2024 167.00 Mn
Dec 31, 2024 167.00 Mn
Sep 30, 2024 172.00 Mn
Sep 30, 2024 172.00 Mn
Jun 30, 2024 175.00 Mn
Jun 30, 2024 175.00 Mn
Mar 31, 2024 136.00 Mn
Mar 31, 2024 136.00 Mn
Dec 31, 2023 146.00 Mn
Dec 31, 2023 146.00 Mn